11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Lipid metabolism in cancer.

      1 ,
      The FEBS journal
      Wiley

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Lipids form a diverse group of water-insoluble molecules that include triacylglycerides, phosphoglycerides, sterols and sphingolipids. They play several important roles at cellular and organismal levels. Fatty acids are the major building blocks for the synthesis of triacylglycerides, which are mainly used for energy storage. Phosphoglycerides, together with sterols and sphingolipids, represent the major structural components of biological membranes. Lipids can also have important roles in signalling, functioning as second messengers and as hormones. There is increasing evidence that cancer cells show specific alterations in different aspects of lipid metabolism. These alterations can affect the availability of structural lipids for the synthesis of membranes, the synthesis and degradation of lipids that contribute to energy homeostasis and the abundance of lipids with signalling functions. Changes in lipid metabolism can affect numerous cellular processes, including cell growth, proliferation, differentiation and motility. This review will examine some of the alterations in lipid metabolism that have been reported in cancer, at both cellular and organismal levels, and discuss how they contribute to different aspects of tumourigenesis.

          Related collections

          Author and article information

          Journal
          FEBS J
          The FEBS journal
          Wiley
          1742-4658
          1742-464X
          Aug 2012
          : 279
          : 15
          Affiliations
          [1 ] Translational Cancer Therapeutics, Cancer Research UK London Research Institute, 44 Lincoln’s Inn Fields, London, UK. claudio.santos@cancer.org.uk
          Article
          10.1111/j.1742-4658.2012.08644.x
          22621751
          8d33a623-1ab7-4dcf-8d17-3f71eacf503c
          © 2012 The Authors Journal compilation © 2012 FEBS.
          History

          Comments

          Comment on this article